{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:54:27Z","timestamp":1770839667030,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00296-019-04444-z","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T06:32:03Z","timestamp":1568961123000},"page":"227-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The same mutation in a family with adenosine deaminase 2 deficiency"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-5644","authenticated-orcid":false,"given":"Betul","family":"Sozeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0744-8970","authenticated-orcid":false,"given":"Gozde","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8310-4053","authenticated-orcid":false,"given":"Ozlem Akgun","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4950-570X","authenticated-orcid":false,"given":"Jale","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-925X","authenticated-orcid":false,"given":"Ferhat","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-6689","authenticated-orcid":false,"given":"Levent","family":"Do\u011fanay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"issue":"10","key":"4444_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV et al (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370(10):911\u2013920","journal-title":"N Engl J Med"},{"issue":"10","key":"4444_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S et al (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370(10):921\u2013931","journal-title":"N Engl J Med"},{"issue":"5","key":"4444_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts I, Aksentijevich I (2018) Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol 38(5):569\u2013578","journal-title":"J Clin Immunol"},{"issue":"1","key":"4444_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/eji.200425738","volume":"35","author":"MS Hershfield","year":"2005","unstructured":"Hershfield MS (2005) New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur J Immunol 35(1):25\u201330","journal-title":"Eur J Immunol"},{"issue":"9","key":"4444_CR5","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1002\/eji.200738094","volume":"38","author":"S Minguet","year":"2008","unstructured":"Minguet S, Dopfer EP, Pollmer C, Freudenberg MA, Galanos C, Reth M et al (2008) Enhanced B-cell activation mediated by TLR4 and BCR crosstalk. Eur J Immunol 38(9):2475\u20132487","journal-title":"Eur J Immunol"},{"issue":"8","key":"4444_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/sj.onc.1206184","volume":"22","author":"S Majumdar","year":"2003","unstructured":"Majumdar S, Aggarwal BB (2003) Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene 22(8):1206\u20131218","journal-title":"Oncogene"},{"issue":"5","key":"4444_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF01115116","volume":"2","author":"HA Simmonds","year":"1982","unstructured":"Simmonds HA, Webster DR, Perrett D, Reiter S, Levinsky RJ (1982) Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency. Biosci Rep 2(5):303\u2013314","journal-title":"Biosci Rep"},{"issue":"2","key":"4444_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G (2010) Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 88(2):279\u2013290","journal-title":"J Leukoc Biol"},{"issue":"3","key":"4444_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1515\/BC.2006.042","volume":"387","author":"S Iwaki-Egawa","year":"2006","unstructured":"Iwaki-Egawa S, Yamamoto T, Watanabe Y (2006) Human plasma adenosine deaminase 2 is secreted by activated monocytes. Biol Chem 387(3):319\u2013321","journal-title":"Biol Chem"},{"issue":"1","key":"4444_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1073\/pnas.75.1.446","volume":"75","author":"WP Schrader","year":"1978","unstructured":"Schrader WP, Pollara B, Meuwissen HJ (1978) Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency. Proc Natl Acad Sci USA 75(1):446\u2013450","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4444_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","volume":"135","author":"L Van Eyck","year":"2015","unstructured":"Van Eyck L, Jr Hershfield MS, Pombal D, Kelly SJ, Ganson NJ, Moens L et al (2015) Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol 135(1):283\u2013287","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4444_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4046\/trd.2017.80.1.77","volume":"80","author":"MJ Bae","year":"2017","unstructured":"Bae MJ, Ryu S, Kim HJ, Cha SI, Kim CH, Lee J (2017) Mycobacterium tuberculosis ESAT6 and CPF10 induce adenosine deaminase 2 mRNA expression in monocyte-derived macrophages. Tuberc Respir Dis (Seoul) 80(1):77\u201382","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"4","key":"4444_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1183\/09031936.96.09040747","volume":"9","author":"L Valdes","year":"1996","unstructured":"Valdes L, San Jose E, Alvarez D, Valle JM (1996) Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J 9(4):747\u2013751","journal-title":"Eur Respir J"},{"issue":"1","key":"4444_CR14","first-page":"87","volume":"21","author":"RA Sari","year":"2003","unstructured":"Sari RA, Taysi S, Yilmaz O, Bakan N (2003) Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol 21(1):87\u201390","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"4444_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00004836-200003000-00011","volume":"30","author":"E Fernandez","year":"2000","unstructured":"Fernandez E, Rodrigo L, Riestra S, Carcia S, Gutierrez F, Ocio G (2000) Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol 30(2):181\u2013186","journal-title":"J Clin Gastroenterol"},{"key":"4444_CR16","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H (2011) Kitas GD Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417","journal-title":"Rheumatol Int"},{"key":"4444_CR17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181384","author":"S Ozen","year":"2019","unstructured":"Ozen S, Bilginer Y, Batu ED, Ta\u015fk\u0131ran E, \u00d6zkara HA, \u00dcnal \u015e, G\u00fcleray N, Erden A, Karada\u011f \u00d6, G\u00fcmr\u00fck F, \u00c7etin M, S\u00f6nmez HE, Ayvaz D\u00c7, Tezcan I (2019) A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2 Subtitle: Deficiency of adenosine deaminase. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.181384","journal-title":"J Rheumatol"},{"issue":"6","key":"4444_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00431-014-2320-8","volume":"173","author":"N Garg","year":"2014","unstructured":"Garg N, Kasapcopur O, Foster J 2nd, Barut K, Tekin A, Kizilkilic O et al (2014) Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr 173(6):827\u2013830","journal-title":"Eur J Pediatr"},{"issue":"8","key":"4444_CR19","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3899\/jrheum.150024","volume":"42","author":"ED Batu","year":"2015","unstructured":"Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M et al (2015) A case series of adenosine deaminase 2- deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol 42(8):1532\u20131534","journal-title":"J Rheumatol"},{"issue":"1534\u20131537","key":"4444_CR20","first-page":"e8","volume":"141","author":"L Trotta","year":"2018","unstructured":"Trotta L, Martelius T, Siitonen T, Hautala T, Hamalainen S, Juntti H et al (2018) ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol 141(1534\u20131537):e8","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"4444_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MPH.0000000000001132","volume":"41","author":"M Sundin","year":"2019","unstructured":"Sundin M, Marits P, Nierkens S, Kolios AGA, Nilsson J (2019) \"Immune\" thrombocytopenia as key feature of a novel ADA2 deficiency variant: implication on differential diagnostics of ITP in children. J Pediatr Hematol Oncol 41(2):155\u2013157","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"4444_CR22","first-page":"480","volume":"371","author":"L Van Eyck","year":"2014","unstructured":"Van Eyck L, Liston A, Wouters C (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371(5):480","journal-title":"N Engl J Med"},{"issue":"9","key":"4444_CR23","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S et al (2016) Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol 68(9):2314\u20132322","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4444_CR24","doi-asserted-by":"publisher","first-page":"O40","DOI":"10.1186\/1546-0096-13-S1-O40","volume":"13","author":"ASD Ombrello","year":"2015","unstructured":"Ombrello ASD, Hoffmann P, Jones A, Barham B, Barron K, Flegel W et al (2015) The deficiency of adenosine deaminase type 2-results of therapeutic intervention. Pediatr Rheumatol 13(1):O40","journal-title":"Pediatr Rheumatol"},{"issue":"8","key":"4444_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-017-0449-8","volume":"37","author":"G Bucciol","year":"2017","unstructured":"Bucciol G, Delafontaine S, Segers H, Bossuyt X, Hershfield MS, Moens L et al (2017) Hematopoietic stem cell transplantation in ADA2 deficiency: early restoration of ADA2 enzyme activity and disease relapse upon drop of donor chimerism. J Clin Immunol 37(8):746\u2013750","journal-title":"J Clin Immunol"},{"issue":"5","key":"4444_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","volume":"55","author":"JM Van Montfrans","year":"2016","unstructured":"Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ et al (2016) Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford) 55(5):902\u2013910","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"4444_CR27","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M et al (2017) ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis 76(10):1648\u20131656","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04444-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04444-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04444-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T04:16:35Z","timestamp":1610597795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04444-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4444"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04444-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"assertion":[{"value":"7 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}